These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4995088)

  • 1. Tremor at rest following cerebellar lesions in monkeys: effect of L-DOPA administration.
    Goldberger ME; Growden JH
    Brain Res; 1971 Mar; 27(1):183-7. PubMed ID: 4995088
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of DL dopa on harmaline induced tremor and on resting tremor in monkeys with tegmental lesions.
    Battista AF; Nakatani S; Goldstein M
    Confin Neurol; 1970; 32(2):332-40. PubMed ID: 4993817
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental tremor following CNS lesions in monkeys.
    Dumont M; Lamarre Y
    Trans Am Neurol Assoc; 1973; 98():237-9. PubMed ID: 4206372
    [No Abstract]   [Full Text] [Related]  

  • 4. Central neural mechanisms contributing to cerebellar tremor produced by limb perturbations.
    Vilis T; Hore J
    J Neurophysiol; 1980 Feb; 43(2):279-91. PubMed ID: 6770052
    [No Abstract]   [Full Text] [Related]  

  • 5. Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
    Goldstein M; Battista AF; Ohmoto T; Anagnoste B; Fuxe K
    Science; 1973 Feb; 179(4075):816-7. PubMed ID: 4630708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions.
    Goldstein M; Battista AF; Nakatani S; Anagnoste B
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1113-6. PubMed ID: 4982245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of cerebellar dyssynergia.
    Gilman S
    Mod Trends Neurol; 1970; 5(0):60-79. PubMed ID: 4277713
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible effect of L-dopa on tremor and catatonia induced by alpha-methyl-p-tyrosine.
    Bédard P; Larochelle L; Poirier LJ; Sourkes TL
    Can J Physiol Pharmacol; 1970 Jan; 48(1):82-4. PubMed ID: 4984213
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of changes in mechanical state of limb on cerebellar intention tremor.
    Vilis T; Hore J
    J Neurophysiol; 1977 Sep; 40(5):1214-24. PubMed ID: 409809
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced relief of the tremor in monkeys with mesencephalic lesions.
    Goldstein M; Battista AF; Nakatani S; Anagnoste B
    Nature; 1969 Oct; 224(5217):382-4. PubMed ID: 4981037
    [No Abstract]   [Full Text] [Related]  

  • 11. Origins of tremor.
    Elble RJ
    Lancet; 2000 Apr; 355(9210):1113-4. PubMed ID: 10791368
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental treatment of parkinsonism with L-Dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    Neurology; 1968 Mar; 18(3):276-7. PubMed ID: 4869717
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). 3. Absorption, distribution and excretion of D- and L-DOPA-14C in rats following intravenous and oral administration.
    Shindo H; Nakajima E; Kawai K; Miyakoshi N; Tanaka K
    Chem Pharm Bull (Tokyo); 1973 Apr; 21(4):817-25. PubMed ID: 4727354
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of recovery following cerebellar deep nuclear lesions in monkeys.
    Goldberger ME; Growdon JH
    Exp Neurol; 1973; 39(2):307-22. PubMed ID: 4634006
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhythmic unit firing in the precentral cortex in relation with postural tremor in a deafferented limb.
    Joffroy AJ; Lamarre Y
    Brain Res; 1971 Apr; 27(2):386-9. PubMed ID: 4994680
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 18. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 19. Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation.
    Defer GL; Remy P; Malapert D; Ricolfi F; Samson Y; Degos JD
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):987-9. PubMed ID: 8057126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-dopa in Parkinson's disease.
    Godwin-Austen RB; Tomlinson EB; Frears CC; Kok HW
    Lancet; 1969 Jul; 2(7613):165-8. PubMed ID: 4183130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.